We are live on ! Find out more
NVO

Novo Nordisk
NVO

707 hedge funds and large institutions have $8.87B invested in Novo Nordisk in 2021 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 259 increasing their positions, 210 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 259 | Existing positions reduced: 210

21% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 56

1% more funds holding

Funds holding: 702 → 707 (+5)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

0.5% less ownership

Funds ownership: 15.06% → 14.56% (-0.5%)

7% less capital invested

Capital invested by funds: $9.54B → $8.87B (-$665M)

21% less call options, than puts

Call options by funds: $21.8M | Put options by funds: $27.5M

Holders
707
Holders Change
+5
Holders Change %
+0.71%
% of All Funds
12.41%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
68
Increased
259
Reduced
210
Closed
56
Calls
$21.8M
Puts
$27.5M
Net Calls
-$5.73M
Net Calls Change
-$19.1M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$132M
2
FP
Financial Perspectives
Minnesota
+$40M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$30.3M
4
Capital International Investors
Capital International Investors
California
+$25.2M
5
Millennium Management
Millennium Management
New York
+$25M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$142M
2
F
Folketrygdfondet
Norway
-$101M
3
AAMU
Amundi Asset Management US
Massachusetts
-$48M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$46.5M
5
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$37.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
GIA
401
Guyasuta Investment Advisors
Pennsylvania
$489K – – –
BAM
402
Barrett Asset Management
New York
$488K +$150K +4,200 +41%
OF
403
Outfitter Financial
Maine
$472K -$33.8K -950 -6%
BFA
404
Beaumont Financial Advisors
Massachusetts
$471K – – –
WOSD
405
WFA of San Diego
California
$470K +$497K +13,940 New
SDWIA
406
Schwarz Dygos Wheeler Investment Advisors
Minnesota
$467K – – –
AWE
407
Avidian Wealth Enterprises
Texas
$463K +$53.7K +1,508 +12%
BST
408
Bath Savings Trust
Maine
$462K -$14.2K -400 -3%
IFO
409
Independent Family Office
New York
$462K – – –
CA
410
Cullinan Associates
Kentucky
$452K – – –
GSIS
411
Global Strategic Investment Solutions
Arizona
$451K – – –
AAM
412
Advisors Asset Management
Colorado
$451K +$110K +3,082 +30%
JFA
413
JNBA Financial Advisors
Minnesota
$450K – – –
BCM
414
BTR Capital Management
California
$443K – – –
EAM
415
Eagle Asset Management
Florida
$440K +$205K +5,744 +79%
Brown Advisory
416
Brown Advisory
Maryland
$437K +$51.7K +1,452 +13%
CG
417
Colony Group
Massachusetts
$437K +$79.8K +2,240 +21%
SC
418
Solstein Capital
California
$436K +$98.3K +2,760 +27%
MCCP
419
Mission Creek Capital Partners
California
$435K – – –
KFC
420
Klingenstein Fields & Co
New York
$423K -$20.2K -566 -4%
GD
421
Grandfield & Dodd
New York
$420K – – –
GC
422
Giverny Capital
Quebec, Canada
$418K – – –
HNB
423
Huntington National Bank
Ohio
$415K +$55.4K +1,556 +14%
KPWS
424
Kestra Private Wealth Services
Texas
$407K -$28.7K -806 -6%
HPCM
425
High Pointe Capital Management
Illinois
$407K +$15.7K +440 +4%
15 16
17
18 19

NVO Hedge Fund Activity: Q1 2021 in Review

707 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2021, worth a combined $8.87B — down 7% from $9.54B a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new NVO positions and 56 closed out — a net gain of 12 holders — while 259 added to existing stakes and 210 trimmed.

The largest buyer was BlackRock, adding an estimated $132M. The largest seller was Renaissance Technologies, cutting an estimated $142M.

  • 707 institutional investors held Novo Nordisk (NVO) as of Q1 2021, up from 702 in Q4 2020.
  • Funds reported $8.87B of Novo Nordisk stock for Q1 2021, down 7% quarter-over-quarter.
  • 68 funds opened new Novo Nordisk positions in Q1 2021 and 56 closed out, a net change of +12 holders.
  • The largest Novo Nordisk buyer in Q1 2021 was BlackRock, an estimated $132M added.
  • The largest Novo Nordisk seller in Q1 2021 was Renaissance Technologies, an estimated $142M sold.

Based on aggregated 13F filings for Q1 2021.